312 related articles for article (PubMed ID: 34393832)
1. Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction.
Sauerbruch T; Hennenberg M; Trebicka J; Beuers U
Front Physiol; 2021; 12():718783. PubMed ID: 34393832
[TBL] [Abstract][Full Text] [Related]
2. The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice.
Zhang F; Duan Y; Xi L; Wei M; Shi A; Zhou Y; Wei Y; Wu X
Chronobiol Int; 2018 May; 35(5):673-690. PubMed ID: 29381405
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH.
Carino A; Biagioli M; Marchianò S; Fiorucci C; Zampella A; Monti MC; Scarpelli P; Ricci P; Distrutti E; Fiorucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1422-1437. PubMed ID: 31325638
[TBL] [Abstract][Full Text] [Related]
4. Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators.
Fiorucci S; Zampella A; Cirino G; Bucci M; Distrutti E
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H21-H32. PubMed ID: 27765751
[TBL] [Abstract][Full Text] [Related]
5. Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids.
Renga B; Bucci M; Cipriani S; Carino A; Monti MC; Zampella A; Gargiulo A; d'Emmanuele di Villa Bianca R; Distrutti E; Fiorucci S
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H114-26. PubMed ID: 25934094
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid accelerates bile acid enterohepatic circulation.
Zhang Y; Jiang R; Zheng X; Lei S; Huang F; Xie G; Kwee S; Yu H; Farrar C; Sun B; Zhao A; Jia W
Br J Pharmacol; 2019 Aug; 176(16):2848-2863. PubMed ID: 31077342
[TBL] [Abstract][Full Text] [Related]
7. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.
Sorribas M; Jakob MO; Yilmaz B; Li H; Stutz D; Noser Y; de Gottardi A; Moghadamrad S; Hassan M; Albillos A; Francés R; Juanola O; Spadoni I; Rescigno M; Wiest R
J Hepatol; 2019 Dec; 71(6):1126-1140. PubMed ID: 31295531
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5.
Trammell SAJ; Svenningsen JS; Holst JJ; Gillum MP; Kuhre RE
Molecules; 2020 May; 25(10):. PubMed ID: 32443832
[TBL] [Abstract][Full Text] [Related]
9. TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload.
Bidault-Jourdainne V; Merlen G; Glénisson M; Doignon I; Garcin I; Péan N; Boisgard R; Ursic-Bedoya J; Serino M; Ullmer C; Humbert L; Abdelrafee A; Golse N; Vibert E; Duclos-Vallée JC; Rainteau D; Tordjmann T
JHEP Rep; 2021 Apr; 3(2):100214. PubMed ID: 33604531
[TBL] [Abstract][Full Text] [Related]
10. Triglycerides and gallstone formation.
Smelt AH
Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
[TBL] [Abstract][Full Text] [Related]
11. Individual bile acids have differential effects on bile acid signaling in mice.
Song P; Rockwell CE; Cui JY; Klaassen CD
Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
[TBL] [Abstract][Full Text] [Related]
12. Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertension.
Fiorucci S; Distrutti E
Pharmacol Res; 2016 Sep; 111():749-756. PubMed ID: 27475883
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
[TBL] [Abstract][Full Text] [Related]
14. Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1.
Renga B; Cipriani S; Carino A; Simonetti M; Zampella A; Fiorucci S
PLoS One; 2015; 10(11):e0141082. PubMed ID: 26539823
[TBL] [Abstract][Full Text] [Related]
15. The Pharmacology of Bile Acids and Their Receptors.
Fiorucci S; Distrutti E
Handb Exp Pharmacol; 2019; 256():3-18. PubMed ID: 31201555
[TBL] [Abstract][Full Text] [Related]
16. Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity.
Biagioli M; Carino A
Handb Exp Pharmacol; 2019; 256():95-108. PubMed ID: 31119464
[TBL] [Abstract][Full Text] [Related]
17. Bile Acids and Portal Hypertension.
Arab JP; Barrera F; Arrese M
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s83-s86. PubMed ID: 29080345
[TBL] [Abstract][Full Text] [Related]
18. [What the (abdominal) surgeon needs to know on novel insights regarding cholic acids and their interaction with the intestinal microbioma].
Schönfeld P; Meyer F
Z Gastroenterol; 2020 Mar; 58(3):245-253. PubMed ID: 32018318
[TBL] [Abstract][Full Text] [Related]
19. Bile Acids and Portal Hypertension.
Pablo Arab J; Barrera F; Arrese M
Ann Hepatol; 2017 Nov; 16 Suppl 1():S83-S86. PubMed ID: 31196639
[TBL] [Abstract][Full Text] [Related]
20. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]